PPARGC1A and cardiac hypertrophy: Recent data have demonstrated NF-κB activation resulted in reduced PGC-1α and Pyruvate dehydrogenase kinase 4 (PDK4) expression[16,17], contributing to cardiac metabolism in the process of cardiac hypertrophy[18,19].